Cilostazol 00093-2064
Product NDC
00093-2064- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 24, 2012
- Listing Expires
- December 31, 2026
- Application
- ANDA077027
Need to source Cilostazol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cilostazol | 100 mg/1 |
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitors [MoA]
Packaging Options(2)
60 TABLET in 1 BOTTLE (0093-2064-06)
5000 TABLET in 1 BOTTLE (0093-2064-50)